AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Exploring Prognostic and Surrogate Markers in MRD Analysis
This chapter delves into the distinctions between prognostic and surrogate markers in the context of MRD in blood cancers, particularly myeloma. It discusses the impact of achieving MRD negativity on outcomes like progression-free and overall survival, examining the relationship between interventions to achieve MRD negativity and improved survival rates.